Skip to main content
. Author manuscript; available in PMC: 2015 Mar 4.
Published in final edited form as: Lancet Neurol. 2013 Oct 30;12(12):1159–1169. doi: 10.1016/S1474-4422(13)70258-8

Table 5.

Comparison of interferon score and type I interferon activity measured in serum of mutation positive patients, by patient number

Gene Age at
sampling
(years)
Interferon
score
Serum
interferon
activity
(IU/mL)
AGS044 TREX1 13·21 30·999 50, 9*
AGS060 TREX1 12·93 12·954 <3
AGS205 TREX1 22·07 20·360 6
AGS635 TREX1 174 17·557 100
AGS015 RNASEH2B 12·01 2·149 <3
AGS068 RNASEH2B 7·73 10·371 12
AGS068 RNASEH2B 8·05 8·163 5
AGS266 RNASEH2B 5·19 61764 25
AGS534 RNASEH2B 0·96 11·020 50
AGS081_P1 ADAR 1578 45·676 12
AGS081_P3 ADAR 5·28 21·590 12
AGS251 ADAR 9·27 12·301 <2, <3*
AGS430_P1 ADAR 5·53 14·306 5, 3*
AGS430_P2 ADAR 5·53 21·538 6
*

Measurements repeated in a separate aliquot of serum taken on the same day of sampling.